According to a recent LinkedIn post from Seqera, the company is highlighting how its customers use protein structure prediction workloads that require substantial GPU resources. The post describes using Nebius Cloud to connect Nextflow executions and run these workloads through NVIDIA NIMs to improve performance.
The LinkedIn post suggests this setup can deliver around a fourfold improvement versus launching containers natively, enabling a significant increase in the number of experiments that can be run. For investors, the emphasis on scaling AI workloads and deepening the partnership with Nebius Cloud may indicate growing demand for Seqera’s workflow orchestration capabilities in high-performance computing and bioinformatics.
This focus on performance and scalability could strengthen Seqera’s positioning in the AI-driven life sciences and research infrastructure market. If such technical advantages translate into broader adoption by enterprise and research customers, the company may see enhanced revenue potential and strategic value within the cloud-native data and compute orchestration ecosystem.